FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Leo Pharma Calcipotriene Cream 0 Recall

Calcipotriene Cream 0

LEO PHARMA INC · Madison, NJ

Risk level
Class II
Reported by FDA
Mar 15, 2017
Recall ID
D-0510-2017
Check your lot numberHow we source this data

Summary

Leo Pharma recalled Calcipotriene Cream 0 starting Jan 19, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0510-2017 on Mar 15, 2017. Reason: Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling. Status: Terminated.

Why it was recalled

Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling.

Product description

Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Manufactured by: LEO Pharma Inc., Dublin, Ireland, Manufactured for: Prasco Laboratories, Mason, OH, 45040

Lot numbers, UPCs & expiration codes

Lot #: a) EK8760, Exp 2/17; EL1115, Exp 3/17; EL2358, Exp 4/17; EL6143, Exp 7/17; EM0837, Exp 10/17; EM2088, 12/17; A20899, Exp 5/18; A24492, Exp 6/18; b) EK8764, Exp 2/17; EL6145, Exp 7/17; EM2091, Exp 2/17; A25206, Exp 6/18.

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0510-2017
Classification
Class II
Status
Terminated
Recall initiated
Jan 19, 2017
FDA report date
Mar 15, 2017
Quantity
272,062 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
LEO PHARMA INC

Original FDA data

Every field from FDA enforcement report D-0510-2017, exactly as published.

Show all FDA fields
City
Madison
State
NJ
Status
Terminated
Country
United States
Event ID
76467
Address
7 Giralda Farms
Code information
Lot #: a) EK8760, Exp 2/17; EL1115, Exp 3/17; EL2358, Exp 4/17; EL6143, Exp 7/17; EM0837, Exp 10/17; EM2088, 12/17; A20899, Exp 5/18; A24492, Exp 6/18; b) EK8764, Exp 2/17; EL6145, Exp 7/17; EM2091, Exp 2/17; A25206, Exp 6/18.
Postal code
07940-1051
Report date
Mar 15, 2017
Product type
Drugs
Recall number
D-0510-2017
Classification
Class II
Recalling firm
LEO PHARMA INC
Product quantity
272,062 tubes
Termination date
Jan 24, 2018
Reason for recall
Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Manufactured by: LEO Pharma Inc., Dublin, Ireland, Manufactured for: Prasco Laboratories, Mason, OH, 45040
Distribution pattern
U.S. Nationwide
Recall initiation date
Jan 19, 2017
Initial firm notification
Letter
Center classification date
Mar 3, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0510-2017, published Mar 15, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls